CompletedNCT04782739
Impact of COVID-19 on Provision and Uptake of Prevention of Mother-to-child Transmission of HIV Services in Zimbabwe
Studying Congenital syphilis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Zimbabwe
- Principal Investigator
- Mutsa Bwakura-DangarembiziUniversity of Zimbabwe Clinical Research Centre
- Intervention
- None - Descriptive study(other)
- Enrollment
- 30 enrolled
- Eligibility
- All sexes
- Timeline
- 2021 – 2022
Study locations (2)
- Kuwadzana Polyclinic, Harare, Zimbabwe
- Mabvuku Polyclinic, Harare, Zimbabwe
Collaborators
Ministry of Health and Child Welfare, Zimbabwe · Centre for Sexual Health and HIV/AIDS Research Zimbabwe (CeSHHAR Zimbabwe) · PENTA Foundation · ViiV Healthcare · University College, London
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04782739 on ClinicalTrials.govOther trials for Congenital syphilis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07189208Evaluation of Antimicrobial Prophylaxis to Prevent Syphilis in Pregnancy in Patients at Risk in Rio de Janeiro, BrazilUniversity of California, Los Angeles
- RECRUITINGNANCT05951751The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)Institut de Recherche pour le Developpement